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The purpose of this study was to determine the extent 
of regional variability of image echocardiographic am•
plitude (expressed as gray level variability) in contrast•
enhanced two-dimensional echocardiographic images, 
and to assess the effect of such baseline gray level var•
iability on quantitation of the coronary perfusion bed. 
In 10 anesthetized closed chest dogs, short-axis pap•
illary muscle echocardiographic images were obtained 
during control preinjection conditions and during injec•
tion of three contrast agents into the left main coronary 
artery with and without circumflex artery occlusion. Re•
gional echocardiographic amplitude variation was mea•
sured by computer-based videodensitometric analysis of 
mean gray levels in four myocardial regions after cavity 
(background) gray level subtraction. To determine the 
effect of regional gray level variability on quantitation 
of the coronary perfusion bed, the contrast-enhanced 
left anterior descending artery perfusion bed was mea•
sured by two methods. The circumferential method ig•
nored myocardial contrast inhomogeneity by measuring 
the circumferential extent of contrast enhancement, 
whether or not the enhancement by contrast medium 
extended transmurally. The exact method measured only 
the area of myocardium actually enhanced by contrast 
The size of the perfusion bed of a coronary artery is an 
important determinant of myocardial infarct size after coro•
nary occlusion (1), Although coronary arteriography pro-
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medium, which often did not extend transmurally. The 
perfusion beds determined by the two echocardiographic 
methods were compared with the anatomic perfusion bed 
determined by postmortem barium-gelatin coronary ar•
teriography. Regional gray levels varied qualitatively 
and quantitatively in the control state (before contrast 
injection), with lateral regions being less bright than 
axial regions. After injection of contrast medium, bright•
ness increased in all regions, the axial regions bright•
ening most. After circumflex artery occlusion, left an•
terior descending perfusion beds were determined by 
circumferential and exact methods. Correlation of each 
method with angiographic perfusion beds revealed a sig•
nificant correlation (r = 0.69) only between the circum•
ferential method and angiography. 
It is concluded that significant baseline regional vari•
ation in contrast-enhanced echocardiographic images oc•
curs unrelated to anatomic distribution of contrast agent. 
This variability is attributable to factors intrinsic to the 
ultrasound imaging technique. In this experimental study, 
the circumferential method of measuring the coronary 
perfusion bed partially compensated for these artifactual 
contrast deficits. 
(] Am Coil CardioI1985;6:831-8) 
vides anatomic information about arterial caliber, it only 
indirectly estimates the amount of myocardium supplied by 
a given coronary artery. This estimate is usually based on 
the size of the vessel and its distal arborization rather than 
on any direct measurement of myocardial mass served by 
the artery. There are currently two clinically feasible meth•
ods of estimating the size of the coronary perfusion bed. 
First, ischemia may be induced in a region served by a 
stenosed coronary artery by either exercise stress or dipyr•
idamole infusion (2) followed by thallium scanning to vi•
sualize the resultant myocardial perfusion defect. Second, 
intracoronary injection of radioactive particles may be done 
during coronary angiography (3). Both methods have lim-
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itations: Stress thallium scanning depends on the presence 
of a flow-limiting stenosis, sufficient stress to induce isch•
emia, the anatomic distribution of the resultant ischemia and 
the presence or absence of other ischemic regions (2). Intra•
coronary injection of radioactive particles requires careful 
control of particle size and number. Also, because of the 
limited number of available isotopes, it is limited to the 
study of one artery at rest and during a stress maneuver or 
to right and left coronary arteries at rest (3). Thus, clinical 
assessment of the coronary perfusion bed (the coronary risk 
region) remains problematic. 
Contrast-enhanced two-dimensional echocardiography has 
been suggested as a method of defining the coronary per•
fusion bed (4-7). Using echocardiography, the myocardium 
may be repeatedly tomographically imaged during selective 
coronary injection of ultrasound reflective agents, thus per•
mitting measurement of the amount of myocardium supplied 
by each coronary artery. Ultrasound images, however, are 
influenced not only by the acoustic properties of the tissue 
being imaged but also by physical factors inherent in the 
ultrasound technique (8-11). Thus, even when the acoustic 
properties of an object are uniform, factors such as trans•
ducer frequency, the method of time-gain compensation and 
the position of the object within the acoustic beam have 
been shown to cause variation in regional image echocar•
diographic amplitude (9). In fact, the acoustic properties 
are not uniform, thereby complicating image analysis fur•
ther. Thus, Zwehl et al. (12), in a blood-filled balloon model, 
showed that measurement of regional contrast intensity is 
significantly modified by contrast-related ultrasound atten•
uation in intervening regions and by the amount of contrast 
medium injected and the mode of injection. Whether this 
is also true in vivo was not addressed in their study. 
The two purposes of the present study were: 1) in an in 
vivo canine model, to determine the extent ofregiona1 var•
iability of image echocardiographic amplitude (expressed 
as gray level variability) in contrast-enhanced echocardio•
graphic images before an intervention (such as coronary 
occlusion) that might alter regional image gray levels; and 
2) to assess the effect of regional gray level variability on 
measurement of the coronary perfusion bed by contrast 
echocardiography. 
Methods 
Surgical procedure. Ten adult dogs (weight, 18 to 30 
kg) were studied. The dogs were anesthetized with sodium 
pentobarbital intravenously and mechanically ventilated with 
a Harvard respirator. After a left thoracotomy a snare was 
placed around the circumflex coronary artery distal to the 
first or second marginal branch and exteriorized through the 
thoracotomy wound. The chest was then closed. A Judkins 
catheter was introduced into the femoral artery and advanced 
under fluoroscopic control into the left main coronary os-
tium, where it was left in place during the series of contrast 
injections. Lidocaine, 1.5 mg/kg, was given before and 
during coronary artery occlusion to control ventricular 
arrhythmias. 
Experimental protocol. The dogs were placeq on their 
right side on a specially constructed table with the echo•
cardiographic transducer against the right chest wall. Short•
axis papillary muscle level views were obtained during con•
trol preinjection conditions and during injection of contrast 
agent directly into the left main coronary artery with and 
without circumflex coronary artery occlusion. Catheter po•
sition, equality of distribution of injectate to the left ahterior 
descending and circumflex branches, and circumflex artery 
occlusion were verified by fluoroscopic visualization of a 
diatrizoate meglumine and diatrizoate sodium (Renografin) 
test dose before and after each series of contrast injections. 
If post-contrast injection fluoroscopy showed a change in 
catheter position or incomplete circumflex artery occlusion, 
that series of images was not subjected to further analysis 
and a new series was performed after catheter repositioning 
or reocclusion of the artery. When the circumflex artery was 
occluded, the area not opacified by contrast medium injected 
into the left main coronary artery defined the circumflex 
risk region. The contrast-enhanced region defined the left 
anterior descending perfusion bed. 
Between 5 and 10 ml of each of three contrast agents 
was hand-injected as rapidly as possible: a 1: 1 diatrizoate 
meglumine and diatriioate sodium (Renografin):saline mix•
ture, a 0.15% hydrogen peroxide solution mixed with a 
small amount of blood and a 0.15% hydrogen peroxide 
solution followed by a saline flush. These agents were cho•
sen because they have been previously demonstrated to pro•
vide echocardiographic contrast and have been parenterally 
administered to patients (5,6). Because injections were done 
by hand, the exact rate of injection was not measured. The 
size of the microbubbles injected was not controlled. 
Control preinjection images were taken immediately be•
fore each contrast injection. Sufficient time elapsed between 
contrast injections to permit the image to return to the control 
preinjection state. In most instances this was between 5 and 
10 minutes. 
Image analysis. Images were obtained using a com•
mercially available phased array echocardiograph (Toshiba 
SSH-IOA) with a 2.4 MHz transducer. The instrument was 
not specially tweaked or altered for this study. For each 
animal, overall gain and time-gain compensation controls 
were initially adjusted to provide a control preinjection im•
age in which all regions of myocardium appeared approx•
imately equally bright. These instrument adjustments were 
thereafter left unchanged during injection of contrast ma•
terial. Short-axis papillary muscle level images were re•
corded on videotape in the preinjectiort control state, and 
then after injection of each contrast agent with and without 
circumflex coronary artery occlusion. 
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Figure 1. A short-axis papillary muscle 
image showing the five regions sub•
jected to gray level analysis. The pap•
illary muscles were not included in the 
determination of left ventricular (LV) 
cavity gray level. 
Regional echo amplitude was evaluated by means of com•
puterized videodensitometric analysis of mean gray levels 
in five ventricular regions. Stop-frame images were dis•
played on a high resolution video monitor and digitized 
using a video camera (Sierra Corporation) interfaced to an 
image array processor (DeAnza IP8500, Gould, Inc.) and 
to a host computer (PDP 11/34, Digital Equipment Cor•
poration). The digitization process yielded a 512 x 512 
pixel matrix with 256 possible gray level values per pixel. 
Black was assigned a gray level value of 0, white a value 
of 255, and gradations from black to white were assigned 
intermediate gray level values. Although our digitization 
technique yielded 256 gray levels, the actual number of 
distinguishable gray levels was probably less. The number 
of distinguishable gray levels obtained using this digitization 
technique depends on several factors, including the char•
acteristics of the video monitor on which the image was 
displayed. 
After digitization, an interactive program allowed the 
observer to measure regional average gray level by placing 
a rectangle (of variable dimensions) over a specific region 
of interest in the digitized image, and then to derive the 
average gray level within that region of interest. Care was 
taken to place each region of interest completely within the 
myocardium, scrupulously avoiding inclusion of the bright, 
angle-dependent reflections from specular interfaces (epi•
cardium and endocardium). Thus, each region of interest 
was approximately 1 cm in endocardial to epicardial direc•
tion. A rectangle was also placed over the center of the left 
ventricular cavity of each image, as a method of background 
gray level measurement. 
Mean gray level was measured for each of the following 
five regions of each digitized image: ventricular cavity, top, 
bottom, left and right sides of the image (Fig. 1). The 
papillary muscles were excluded from determination of the 
left ventricular cavity gray level. Anatomically, the top of 
the image in Figure I corresponds to the interventricular 
septum, the bottom to the posterior wall, the left to the 
posteroseptal area and the right to the anterolateral wall. 
Image background correction was achieved by subtracting 
the mean gray level of the cavity region of interest from the 
gray level obtained for each myocardial region of interest. 
Echocardiographic determination of perfusion bed. 
Regional echocardiographic amplitude (gray level) of an 
ultrasound image is known to vary as a function of the 
position within the ultrasound beam of the object being 
imaged (8,9). Thus, even when imaging an object that uni•
formly scatters ultrasound energy, variation in regional 
echocardiographic amplitude (gray level) occurs. To ex•
amine the effect of this variability in gray levels on quan•
titation of the coronary perfusion bed by contrast-enhanced 
echocardiography, we measured the contrast-enhanced left 
anterior descending perfusion bed by two methods: the cir•
cumferential method, which ignored transmural inhomo•
geneity of contrast enhancement; and the exact method, 
which took into consideration regional transmural variability 
of contrast enhancement. The presence or absence of con•
trast was judged visually rather than by quantitative analysis. 
This visual judgment and all actual tracings were made by 
one observer who was unaware of which condition in the 
experiment (that is, preocclusion or during occlusion) was 
represented by the image being traced. The circumferential 
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method of tracing ignored inhomogeneity of transmural 
myocardial contrast enhancement by requiring the observer 
to measure the circumferential extent of contrast enhance•
ment whether the contrast enhancement effect extended 
transmuraliy or was confined to one segment of the wall 
(usually subendocardial). The exact method required the 
observer to trace, as well as possible, the area of myocar•
dium actually enhanced by the contrast medium, which often 
did not extend transmurally. Thus, the exact method con•
sidered contrast inhomogeneity to be a true biologic phe•
nomenon rather than an artifact of the ultrasound technique, 
and thereby to have quantitative importance. 
Figure 2 demonstrates the two methods of measurement 
of the echocardiographic perfusion bed. By the circumfer•
ential method, there are subepicardial areas that fail to be 
enhanced but that are nonetheless included in the measure•
ment of the perfusion bed because subendocardial contrast 
enhancement was seen. However, by the exact method, only 
the area of myocardium actually enhanced by contrast me•
dium was outlined and measured. The left anterior descend•
ing coronary perfusion bed was expressed as percent of total 
left ventricular area. 
Determination of the anatomic perfusion bed. The 
anatomic perfusion beds for the left anterior descending and 
circumflex coronary arteries were determined using methods 
previously described (13,14). The heart was excised after 
the dog was heparinized and diastolic cardiac arrest obtained 
with potassium chloride injection. The right and left coro•
nary arteries were cannulated. The cannulas were secured 
with 2-0 silk ties at the coronary ostia and the coronary 
arteries were flushed with heparinized saline solution to 
remove all blood. A barium-gelatin-formalin mixture was 
then injected simultaneously into both cannulas at a per•
fusion pressure 10 mm Hg above the mean arterial pressure 
recorded during the experiment. Perfusion pressure was 
maintained for 10 minutes to allow solidification of the 
perfusate; the cannulas were then clamped off, and the heart 
was fixed in 10% buffered formalin solution. Radiographs 
of the whole heart were taken in the anteroposterior and 10° 
left anterior oblique positions. The heart was then sectioned 
into five to seven transverse slices of equal thickness parallel 
to the atrioventricular grooves, and a radiograph was taken 
of each ventricular slice arranged in order from base to apex. 
The anatomic perfusion bed of each coronary artery was 
then determined by following the course of each artery and 
its branches from slice to slice using the whole heart radio•
graph as a reference. For example, the circumflex coronary 
artery was located and the course of its major branches and 
sub-branches identified on the radiograph of the whole heart. 
The same coronary artery and its branches were then iden•
tified on the radiograph of the most basal heart slice. The 
radiograph of the next slice was then examined and the same 
artery's branches and sub-branches were identified by re•
ferring to both the preceding slice radiograph and the whole 
heart radiograph. On each slice radiograph, tile myocardial 
boundaries of the anatomic perfusion bed of each artery 
were delineated by marking the myocardial area served by 
the smallest branches of that artery. For example, in Figure 
3 the left anterior descending perfusion bed extends clock•
wise from approximately the 8 o'clock to the 1 o'clock 
position, whereas the circumflex perfusion bed extends from 
the 1 o'clock to the 8 o'clock position .. On each slice ra•
diograph the area of each perfusion bed so identified was 
then determined by planimetry and expressed as a percent 
of the total area of the slice radiograph. The area of the left 
anterior descending perfusion bed at the papillary muscle 
level obtained in this manner was compared with the area 
at the same level as obtained by both echocardiographic 
methods. The anatomic landmark of the midpapillary mus•
cle level was selected because the corresponding echocar•
diographic slice could be easily identified, thereby permit•
ting a close match between the echocardiographic image 
and the anatomic specimen. 
Data analysis. We tested for differences between image 
echocardiographic amplitude (expressed as mean gray level) 
( ± SEM) from one region to another for each contrast agent 
using analysis of variance. Linear regression analysis was 
used to compare angiographic risk region with echocardi-
Figure 2. Circumferential (A) and exact (B) 
methods of measuring the echocardiographic 
perfusion bed. The left anterior descending ar•
tery perfusion bed is outlined by the criteria of 
each method (see text). By the circumferential 
method, there are subepicardial areas that fail to 
opacify but are nonetheless included in the per•
fusion bed measurement because subendocardial 
contrast enhancement is seen. In the exact method, 
the nonenhanced areas are excluded from the 
measurement of the perfusion bed. 
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Figure 3. Postmortem barium-gelatin angio•
gram of a ventricular slice at the papillary muscle 
level. The left anterior descending artery per•
fusion bed extends from the 8 o'clock to the I 
o'clock position. The circumflex perfusion bed 
extends from the I o'clock to the 8 o'clock po•
sition. See text. 
ographicaUy determined risk region by each method. For 
this comparison, all agents were grouped together. A prob•
ability (p) value less than 0.05 was considered significant. 
Results 
Variability in baseline precoronary occlusion im•
ages. Determination of baseline regional image amplitude 
variability was done in the following manner: Images were 
obtained from five dogs during left main coronary artery 
injections of contrast medium without circumflex coronary 
artery occlusion; contrast enhancement of the entire left 
ventricular myocardium was thus obtained. Regional gray 
levels were measured in control preinjection images, and 
then in images resulting from injection of each contrast 
agent. Qualitatively, in the preinjection control images, gray 
levels appeared to vary, with lateral regions being less bright 
than the axial regions (Fig. 4). After injection of each con•
trast agent, overall brightness increased. The top region was 
brightest and the bottom regions tended to be brighter than 
lateral regions. These qualitative findings were confirmed 
by statistical analysis of regional gray levels (Fig. 5). In the 
pre injection control state, the two axial regions (top and 
bottom) were not different from one another but were sig-
Figure 4. Control (pre-contrast injection) image and contrast•
enhanced image resulting from left main coronary artery injection 
of contrast medium without coronary artery occlusion. After in•
jection of contrast material, overall brightness increased, with the 
most striking change in the top region. The ultrasonoscope gain 
and time-gain compensation settings were identical for both 
recordings. 
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Figure 5. Regional gray level variation in control (pre injection) 
images and after injection of each contrast agent. Image regions 
of interest are indicated as T = top, B = bottom, L = left and 
R = right. With each constant agent, the gray levels are highest 
in the top regions and lowest in the lateral regions (L and R). 
nificantly brighter than the lateral (right and left) regions (p 
< 0.05). With left main coronary artery injection of each 
contrast agent, there was an increase in brightness in all 
regions. However, for each agent the top and bottom bright•
ened most with the lateral regions changing least. For any 
given contrast agent, when tile four regions were compared, 
the top was consistently and significantly brighter than bot•
tom or lateral regions (p < 0.05). 
Measurement of left anterior descending perfusion 
bed. After circumflex coronary artery occlusion, echocar•
diographic left anterior descending perfusion beds were de•
termined for all 10 dogs by both the circumferential and 
exact methods. The left anterior descending perfusion bed 
size measured by both echocardiographic methods was then 
correlated with anatomic perfusion bed size. The correla•
tions are shown in Figure 6. There was a significant linear 
correlation between angiography and the circumferential 
method (y = 0.61x + 20.2, r = 0.69), although there was 
no correlation between angiography and the exact method. 
Discussion 
The results of this study demonstrate that there is sig•
nificant baseline regional variation in image gray level 
(echocardiographic amplitude) that is further accentuated by 
contrast enhancement. This image gray level variation ex•
isted before the intervention of coronary artery occlusion, 
which might alter regional gray level by alteration of myo•
cardial tissue. Use of a circumferential method of analysis 
partially compensated for these artifactual regional gray level 
variations. 
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Figure 6. Correlations between the angiographic and the two 
echocardiographic left anterior descending perfusion bed contrast 
enhancement measurement methods. There is a significant cor•
relation only between the circumferential echocardiographic mea•
surement method and angiography. LV = left ventricle. 
Echocardiographic assessment of coronary perfusion 
beds. The size of the coronary perfusion bed is an important 
quantity determining myocardial infarct size (1) and thus 
postinfarction prognosis. Accordingly, it is highly desirable 
to be able to clinically assess coronary perfusion bed size. 
However, current clinical methods of determining the size 
of a given coronary artery perfusion bed are limited. The 
use of echocardiographic contrast agents that can be injected 
during selective or subselective coronary angiography is a 
potential solution to the problem of coronary perfusion bed 
measurement. Selective or subselective contrast enhance•
ment allows quantitative assessment of muscle mass served 
by a coronary artery, the region at risk for infarction should 
coronary occlusion occur. 
When the risk region was experimentally measured by 
this method, Sakamaki et al. (4) found a good correlation 
between left anterior descending artery risk region defined 
by diatrizoate meglumine and diatrizoate sodium (Reno•
grafin)/saline contrast echocardiography and risk region de•
fined by injection of monastral blue dye after left anterior 
descending artery occlusion. Tei and colleagues (5) defined 
coronary risk regions by comparing areas of positive and 
negative contrast. A positive contrast risk region was produced 
by injection into a coronary artery branch, whereas a neg•
ative contrast region was produced by occluding the same 
branch and injecting contrast medium into the left main 
coronary artery. In their study, no comparison to an ana•
tomic standard was made. However, several injections with 
and without occlusion of a given coronary artery branch 
were made and there was good agreement (r = 0.93) in the 
amount of myocardium outlined by positive and negative 
contrast effect. Thus, measurement of perfusion bed by this 
technique appears reproducible. 
These authors (5) also compared the extent of myocar•
dium opacified from a particular intracoronary site and the 
extent of left ventricular asynergy resulting from coronary 
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artery occlusion at the same site. They demonstrated good 
agreement between these two indexes of perfusion area. 
Other investigators (6,7) found that echocardiographic con•
trast defects using hydrogen peroxide contrast enhancement 
were more accurate than extent of wall motion abnormalities 
in predicting hypoperfusion and infarction. This may be 
particularly important when assessing transiently ischemic 
myocardium, a setting in which the functional state of myo•
cardium is disproportionately depressed in relation to ana•
tomic necrosis (15). 
Mechanisms of regional echocardiographic amplitude 
variation. Regional gray level variation is present before 
contrast enhancement and is exaggerated with contrast en•
hancement. Thus, it is of concern whether preexisting re•
gional gray level variation influences the perception of the 
extent of enhancement. What are the factors responsible for 
regional variation in gray levels of an echocardiographic 
image when the substance being imaged is of uniform scat•
tering characteristics? Such factors include beam profile, 
the method of time-gain compensation, distance of the re•
gion of interest from the transducer, the angle at which the 
beam intercepts the object and the acoustic attenuation char•
acteristics of the material being imaged. Gain compensation 
is the process of signal amplification intended to compensate 
for loss of ultrasound energy as it passes through tissue. 
This loss, referred to as attenuation, is due both to absorption 
and to scattering of sound energy. It is a function of distance 
traveled by the beam and the attenuation characteristics of 
the tissue (8-11). The method of gain compensation cur•
rently used is important to consider for our study. Current 
methods of gain compensation amplify the signal based 
solely on the distance between the transducer and the region 
of interest, without regard for the attenuation characteristics 
of the tissues through which the ultrasound beam passes 
along each of the lines-of-sight of a two-dimensional echo•
cardiographic image (8). We believe these attenuation dif•
ferences are one important explanation for the regional var•
iability seen. 
Skorton et al. (9), using a quantitative analysis of spatial 
gray level distributions as a measure of image texture, com•
pared the effects of range (distance from the transducer) and 
azimuth (lateral offset from the centerline of the scan) on 
image texture of a uniformly scattering image phantom. 
They found that texture varied as a function both of range 
and of azimuth, with range being the more important of the 
two factors. Thus, variation in image texture is present when 
the object being imaged has uniform acoustic attenuation 
properties. When the object being imaged is not acoustically 
uniform, the attenuation characteristics of the object may 
vary from region to region, thus further altering the resultant 
image characteristics. For example, the ultrasound scatter•
ing and absorption properties of myocardium are different 
from those of blood; myocardium causes a much greater 
attenuation of energy than blood (8). In Figure 7, the lateral 
Range em 
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Figure 7. Schematic drawing illustrating the effects of differential 
tissue attenuation and beam path length on ultrasound reflection. 
Abbreviations as in Figure 5. 
portion of the beam indicated by line y traverses a longer 
distance through myocardium; thus, relatively less ultra•
sound energy reaches the distal target to be reflected. On 
the other hand, that portion of the beam indicated by line 
x traversing the blood-filled left ventricular cavity will be 
less attenuated. Therefore, more of the energy will reach 
the posterior target to be reflected. Thus, distance, lateral 
offset of the object in the beam, and the attenuation char•
acteristics of the tissue combine to yield differential gray 
levels of acoustically uniform left ventricular myocardium. 
An additional factor that may add to regional gray level 
variation in contrast-enhanced images is the phenomenon 
of acoustic shadowing (12,16,17). When a highly reflective 
object is more proximally located than a second object in 
the ultrasound beam path, an acoustic shadow is cast on the 
distal object so that the more distal object appears less bright 
on the resultant image. Because contrast agents are highly 
reflective of ultrasound, contrast-enhanced regions in the 
near portion of the beam may cast a shadow on regions in 
the more distal position of the beam. This phenomenon 
might be affected by the size of the microbubbles in the 
contrast agent, but this was neither controlled nor measured 
in this study. 
Effect of method of measuring echocardiographic risk 
region. After establishing that significant regional variation 
exists in areas of contrast enhancement when the tissue 
imaged has uniform acoustic characteristics, we wanted to 
determine the effect of this baseline variation during an 
intervention altering the tissue characteristics of the imaged 
myocardium. We therefore measured the coronary perfusion 
bed by two methods. The circumferential method ignored 
contrast inhomogeneity and considered the coronary per•
fusion bed to span a circumferential portion of the left ven•
tricle, whether or not contrast enhancement appeared trans•
murally. The exact method measured only the precise area 
enhanced by contrast medium (Fig. 2), thereby assuming 
that any area not enhanced had a true perfusion deficit rather 
than an artifactual deficit related to the physical factors 
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discussed earlier. When each of these methods was com•
pared with an anatomic measurement of the perfusion bed, 
only the circumferential method significantly correlated with 
the anatomic standard. 
We postulate that the circuniferential method correlated 
with the anatomic perfusion bedfor two reasons: It ignored 
artifactual contrast deficits inherent in the ultrasound tech•
nique, and it conformed to the anatomic distribution of the 
coronary perfusion bed. Scheel et al. (18) showed that the 
perfusion bed of each coronary artery in the dog is sharply 
delineated and principally extends from epicardium to en•
docardium. Thus, the circumferential method in which the 
appearance of any contrast enhancement assumed trans•
mural distribution of the coronary perfusion bed corresponds 
best to the anatomic pattern of the coronary perfusion beds. 
There are regions of canine myocardium in which this is 
not true-namely, the papillary muscles themselves (as op•
posed to left ventricle at the level of the papillary muscle), 
and the apical region, where there may be more endocardial•
epicardial variation in blood supply. However, these are 
relatively small regions and would be unlikely to introduce 
a substantial error into measurement of the perfusion bed. 
In chronic coronary occlusion, coronary artery collateral 
vessels that develop may have a different endocardial to 
epicardial anatomic distribution; therefore, the circumfer•
ential method may not apply as well in this situation. Be•
cause coronary anatomy in patients with coronary artery 
disease is more variable as a result of collateral vessel for•
mation and because multiple coronary stenoses may be pres•
ent that might alter the distribution of contrast agent, the 
effect of coronary artery disease on the echocardiographic 
measurement of perfusion beds in humans requires further 
study. Thus, the results of this study cannot be applied 
directly to clinical use. 
Contrast agents. Agents providing echocardiographic 
contrast must be safe for use in humans, must provide rapid, 
reliable contrast on a single bolus injection and must rapidly 
clear from the microcirculation both to prevent capillary 
occlusion and to permit multiple injections if needed. Sev•
eral such agents are being studied, among them standard 
angiographic contrast dye (4,5), dilute hydrogen peroxide 
(5,15) and gelatin microbubbles (6). Both agents used in 
our study have been administered parenterally, though hy•
drogen peroxide has not been injected intraarterially in hu•
mans. Gaffney et al. (19) showed that intravenous hydrogen 
peroxide is safe for human use. Further studies are necessary 
before intraarterial hydrogen peroxide can be used in pa•
tients. Additional studies must also be performed to deter•
mine how volume or infusion rate of contrast agent, size of 
microbubbles or viscosity of contrast agent affects the mea•
surement of the contrast -enhanced perfusion bed; the in vitro 
balloon study of Zwehl et al. (12) suggests that these factors 
are important. 
Conclusions. We have demonstrated that baseline re•
gional gray level variation exists in two-dimensional echo-
cardiographic images before contrast enhancement and is 
further accentuated by contrast enhancement. This regional 
variability must be considered when using contrast echo•
cardiography to measure the coronary perfusion bed. 
We thank Mary E. McDermott for expert assistance in preparation of this 
manuscript and Douglas Thompson for radiography of hearts used in this 
study. 
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